The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer

Objective: To determine the efficiency of transabdominal and transvaginal ultrasonography (TAS and TVS) in the assessment of myometrial invasion, cervical involvement, pelvic lymph nodes, adnexal and omental metastases (preoperative staging) of endometrial cancer.

Methods: Transabdominal and transvaginal 2D, ultrasound were performed on 90 women to classify myometrial invasion, cervical involvement, pelvic lymph nodes and adnexal metastases in endometrial cancer. According to this 13 type E (invasion involving the endometrium), 41 type S (superficial, of less than 50% of myometrial infiltration), 36 type D (deep infiltration) and 22 cervical involvement were identified. There were 15 G1, 60 G2 and 15 G3 cases. Adnexal, omental and lymph-node metastases were found in 11, two and 15 cases, respectively. Endometrial cancer was diagnosed on the basis of dilatation and curettage. The degree of invasion was evaluated preoperatively. Ultrasonographic findings were compared to surgical staging and histopathology of the surgical specimen.

Results: The median age of the 90 women was 63.3 +/- 12.3 years (range 32 to 86 years). The median thickness of malignant endometrium was 19.5 +/- 9.6 (range 7 to 54 mm). In type E the median thickness was 11.76 +/- 4.2, in type S 17.3 +/- 7.6, in type D 24.8 +/- 9.8 and in cases with cervical involvement 23.2 +/- 11 mm. Myometrial invasion evaluated by TVS was accurate in 76 of 90 cases (accuracy 84.4%). In type E sensitivity was 92.3%, specificity 87.0%, positive and negative predictive value, respectively, 63.1% and 98.6%. In type S these values were respectively: 78.0%, 93.9%, 91.4%, 80.0% and in type D--88.9%, 92.6%, 88.9% and 100.0%. Tumor extension to the cervix was properly assessed in 19 of 22 women in which it was present (sensitivity 86.4%, specificity 85.3%, positive predictive value 85.5%, negative predictive value 95.1%). Adnexal metastasis was correctly diagnosed in 8 of 11 cases in which it was present (sensitivity 72.7%, specificity 97.5%, positive predictive value 80%, negative predictive value 96.3%), and lymph-node metastasis in only 5 of 15 cases (sensitivity 33.3%, specificity 100%, positive predictive value 100%, negative predictive value 88.2%).

Conclusion: These results suggest that 2D TAS and TVS evaluation of endometrial cancer are reliable methods for preoperative assessment of selected prognostic factors, e.g. myometrial invasion, cervical involvement and adnexal metastases. However in assessing lymph-node metastases, TVS with its low sensitivity, did not provide additional information. Preoperative ultrasound examination should be speculated as an important tool in the establishment of different surgical choices which can be made after a correct pretreatment prognosis.

Endometrial cancer; Prognostic factors; Transabdominal and transvaginal ultrasonography

[1] Creasman W. T.: "New gynecologic cancer staging". Obstet Gynecol., 1990, 75, 287.

[2] Lerner J. et.al.: "Use of transvaginal sonography in the evaluation of endometrial hyperplasia and carcinoma". CME J. Gynecol Oncol., 1996. 51 (12), 718.

[3] Cagnazzo G., D'Addario V., Martinelli G. et al.: "Depth of myometrial invasion in endometrial cancer: Preoperative assessment by transvaginal ultrasonography and magnetic resonance imaging". Ultrasound Obstet. Gynecol., 1992, 2, 40.

[4] Mikuta J. J.: "Preoperative evaluation and staging of endometrial cancer". Cancer, I 995, 76, 2041.

[5] Karlsson B., Norstrom A., Grandberg S.: "The use of endovaginal ultrasound to diagnose invasion of the endometrial carcinoma" Ultrasound Obstet. Gynecol., 1992, 2, 35.

[6] Adcock L. L., Julian T. M.. Okagaki T.: "Carcinoma of the uterine cervix FIGO stage lb". Gynecol. Oncol., 1982, 14, 199.

[7] Achiron R., Grisaru D., Golan-Porat N.: "Tamoxifen and the uterus: an old drug tested by new modalities“ Ultrasound Obstet Gynecol., 1996, 7, 374.

[8] Gull B., Karlsson B., Milsom T., Wikland M.: "Transvaginal sonography of the endometrium in a representative sample of postmenopausal women". Ultrasound Obst et. Gynecol., 1996, 7, 322.

[9] Sheth S., Hamper U., McCollum M.: "Endometrial blood flow analysis in postmenopausal women(..an it help differentiate benign from malignant causes of endometrial thickening?". Radiology, 1995, 195, 661.

[10] Ambrose R. A.. Kurman R. J.: "Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus". Cancer, 1992, 69, 1424.

[11] Gordon A., Fleischer A., Reed G.: "Depth of myometrial mvasion in endometrial cancer: Preoperative assessment by transvaginal ultrasonography". Gynecol. Oncol., 1990, 39, 321.

[12] Karlsson B., Norstrom A., Granberg S. et al.: "The use of endovaginal ultrasound to diagnose invasion of endometrial carcinoma". Ultrasound Obstet. Gynecol., 1992, 2, 35.

[13] Osmers R., Osmers M., Kuhn W.: "Prognostic value of transvagi-nal sonography in asymptomatic endometrial cancers". Ultrasound Obstet. Gynecol., 1995, 6, 103.

[14] Weber G., Merz E., Bahlmann F. et al.: "Assessment of myometrial infiltration and preoperative staging by transvaginal ultrasound in patients with endometrial carcinoma". Ultrasound Obstet. Gynecol., 1995, 6, 362.

[15] Calitchi E., Lobo P., Martin M.: "The role of radiation therapy in the treatment of adenocarcinoma in the corpus uteri stage I: a ten year experience (1970-1979)". Acta Radiol. Oncol., 1984, 23, 461.

[16] Gusberg S:.'The individual at high risk for endometrial carCInoma". Am. J. Obstet. Gynecol., 1976, 126, 535.

[17] Annual report of treatment in gynecological cancer, H.L. Koffmeier (ed.), Stockholm; Currie J.L: "Malignant tumors of the uterine corpus". In the Linde's Operative Gynecology, 7th ed., 1992, 1253.

[18] Girardi F: 'The importance of histologic processing of pelvic lymph nodes in the treatment of cervical cancer". Int. J. Gynecol. Cancer, 1993, 3, 12.

[19] Pilleron J. P: "Progno寸ic value of node metastases in cancer of the uterine cervix". Am. J. Obstet. Gynecol., 1974, 119, 458.

[20] Mamsen A., Ledertoug S., Horlyck A.:'The possible role of ultrasound in early cervical cancer". Gynecol. Oneal., 1995, 56, 187.

[21] Cobby M., Browning J., Jones A: "MRI, CT, and endosonography in the local staging of carcinoma of the cervix". Br. J. Radiol., 1990, 63, 673.

[22] Artner A., Bosze P., Gonda G.: "The value of ultrasound m preoperative assessement of the myometrial and cervical invasion in endometrial carcinoma". Gynecol. Oncol., 1994, 54 (2), 147.

[23] King L. A., Talledo 0. E., Gallup D. G.: "Computed tomography in evaluation of gynecologic malignancies: A retrospective analysis". Am. J. Obstet. Gynecol., 1986, 155, 5, 960.

[24] Gabrielli S., Marabini A., Bevini M., Linsalata I.: "Transvaginal sonography vs. hysteroscopy in the preoperative staging of endometrial carcinoma". Ultrasound Obstel. Gynecol., 1996, 7, 443.

[25] Gordon A. N., Fleischer A. C., Reed G. W.: "Depth of myometrial invasion in endometrial cancer: preoperative assessment by transvaginal sonography". Gynecol. Oncol., 1990, 39, 321.

[26」Lehtovirta P., Ylostalo P.: "Serum CA-125 levels and sonography in the pre-operative assessment of myometrial invasion of endometrial cancer". Br. J. Obstet. Gynecol., 1994, 101, 532.

[27] Artner A., Bosze P., Gonda G.: "The value of ultrasound m preoperative assessement of the myometrial and cervical invasion in endometrial carcinoma". Gynecol. Oneal., 1994, 54 (2), 147.

[28] Granberg S., Wickland M., Karlsson B. et al.: "Endometrial thickness as measured by endovaginal ultrasound for identifying endometrial abnormality". Am. J. Obstet. Gynecol., 1991, 164, 47.